Zhejiang Hisun Pharmaceutical Co., Ltd. (SHA:600267)
China · Delayed Price · Currency is CNY 10.36
-0.28 (-2.63%)
Apr 8, 2026, 3:00 PM CST
SHA:600267 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 547.49 | 601.18 | -93.17 | 488.86 | 486.89 |
Depreciation & Amortization | 978.63 | 1,081 | 1,048 | 1,040 | 951.73 |
Other Amortization | 2.95 | 9.37 | 3.26 | 5.59 | 6.35 |
Loss (Gain) From Sale of Assets | -5.23 | -0.72 | 11.49 | 2.06 | 46.71 |
Asset Writedown & Restructuring Costs | 250.57 | 4.12 | 193.21 | 0.57 | 2.24 |
Loss (Gain) From Sale of Investments | 34.72 | -158.58 | -72.1 | 1.02 | -87.75 |
Provision & Write-off of Bad Debts | - | 86.75 | 23.48 | -9.53 | 12.7 |
Other Operating Activities | 153.48 | 372.46 | 343.48 | 487.51 | 482.38 |
Change in Accounts Receivable | 33.09 | 277.84 | 118.04 | -398.93 | -31.43 |
Change in Inventory | 66.09 | 69.13 | -170.73 | 19.03 | 398.83 |
Change in Accounts Payable | -59.35 | -241.5 | 167.61 | 362.18 | -585.72 |
Change in Other Net Operating Assets | 0.51 | 5.99 | 9.15 | 46.7 | 20.26 |
Operating Cash Flow | 2,032 | 2,115 | 1,503 | 2,066 | 1,737 |
Operating Cash Flow Growth | -3.92% | 40.72% | -27.26% | 18.96% | 9.24% |
Capital Expenditures | -376.4 | -238.44 | -240.04 | -530.62 | -622.38 |
Sale of Property, Plant & Equipment | 14.68 | 11.23 | 26.46 | 91.62 | 203.67 |
Divestitures | - | - | 23.1 | 43.45 | - |
Investment in Securities | -78.28 | -9.23 | -20.56 | -43.06 | -99.93 |
Other Investing Activities | 70.9 | 16.98 | -127.71 | -140.17 | 25.35 |
Investing Cash Flow | -369.1 | -220.8 | -338.71 | -578.78 | -493.28 |
Short-Term Debt Issued | - | 300 | - | 898.8 | 998.55 |
Long-Term Debt Issued | 2,358 | 4,092 | 3,831 | 4,606 | 6,649 |
Total Debt Issued | 2,358 | 4,392 | 3,831 | 5,504 | 7,647 |
Short-Term Debt Repaid | - | -304.04 | -608.54 | -813.27 | -508.63 |
Long-Term Debt Repaid | -3,558 | -5,798 | -3,786 | -6,216 | -8,912 |
Total Debt Repaid | -3,558 | -6,103 | -4,395 | -7,030 | -9,421 |
Net Debt Issued (Repaid) | -1,201 | -1,710 | -564.17 | -1,525 | -1,773 |
Issuance of Common Stock | - | - | - | 23.29 | 922.14 |
Repurchase of Common Stock | - | -172.78 | -109.23 | -211.66 | -101.62 |
Common Dividends Paid | -343.42 | -148.47 | -356.3 | -381.25 | -417.3 |
Other Financing Activities | -89.46 | -5.25 | 25.49 | 589.57 | -703.79 |
Financing Cash Flow | -1,633 | -2,037 | -1,004 | -1,505 | -2,074 |
Foreign Exchange Rate Adjustments | -0.89 | 3.47 | 4.72 | 6.53 | -0.6 |
Net Cash Flow | 28.3 | -139.74 | 164.47 | -11.92 | -831.37 |
Free Cash Flow | 1,655 | 1,876 | 1,263 | 1,535 | 1,114 |
Free Cash Flow Growth | -11.77% | 48.59% | -17.75% | 37.78% | 24.13% |
Free Cash Flow Margin | 15.69% | 19.17% | 12.17% | 12.75% | 9.18% |
Free Cash Flow Per Share | 1.41 | 1.61 | 1.08 | 1.32 | 0.98 |
Cash Income Tax Paid | 805.55 | 626.07 | 643.89 | 666.43 | 667.02 |
Levered Free Cash Flow | 1,366 | 1,459 | 686.12 | 1,115 | 1,176 |
Unlevered Free Cash Flow | 1,366 | 1,557 | 820.75 | 1,292 | 1,392 |
Change in Working Capital | 69.06 | 118.48 | 45.29 | 49.72 | -164.73 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.